Develop antibodies against new, next generation targets involved in cancer immune modulation

Delineation of the intra-tumor microenvironment in a dynamic, spatiotemporal setting is critical for investigating the activity and efficacy of candidate oncology drugs. The majority of solid cancers contain unorganized, highly complex microenvironments wherein a dysregulated phenotype impacts treatment outcomes at a personalized level.